💡 50% of hires happen without a job posting·⚡ Apply spontaneously to dozens of companies📈 Track opens & CV clicks

Seqalis
Public profile- Gosselies, Belgium
- 11-50 collaborators
- Pharmaceutical/Biotech
- and 1 others
- Gosselies, Belgium
- 11-50 collaborators
- Pharmaceutical/Biotech
- and 1 others
Overview Seqalis
https://www.seqalis.com/About us
What we do: Seqalis™ is a Belgian life sciences company specializing in high-quality laboratory testing, scientific advisory, and research and development services. Our expertise spans Anatomical Pathology, Cytogenomics, and Molecular Biology, including advanced techniques such as next-generation sequencing (NGS), immunological monitoring, and T cell repertoire analysis. We support healthcare innovation by providing customized analytical services to pioneering companies in the pharmaceutical, biotechnology, and healthcare sectors. Our mission is to be a key partner in scientific projects, adapting our services to the technological needs of the future and fostering progress in life sciences[1].
Where we are located: Our headquarters is located at 25, avenue Georges Lemaître, Gosselies, Charleroi 6041, Belgium. This modern facility serves as the central hub for our laboratory operations and scientific collaborations[3].
Short history: Seqalis™ was established as a trademark of BIO.be S.A. in June 2022, building on a legacy that traces back to the founding of the Institute of Pathology and Genetics (IPG) in 1958. Key milestones include the creation of the IPG Human Genetics Centre in 1968, the launch of molecular biology, anatomic pathology, and cytogenetics services in 2013, the introduction of NGS services in 2021, and the creation of immune monitoring services in 2022. We maintain a close collaboration with IPG, one of Belgium’s eight Genetics Centres, to foster continuous innovation in medical diagnostics[2].
Organization & culture: Seqalis employs between 11 and 50 professionals who share values of integrity, teamwork, and excellence. Our culture emphasizes collaboration and scientific rigor, creating an environment where each team member contributes to advancing life sciences and healthcare diagnostics. We believe in cross-pollination of ideas and maintain strong ties with our parent organization to drive innovation[3].
Recent developments: Seqalis actively participates in significant research projects such as phase 2 of the AURORA breast cancer research initiative, led by the Breast International Group. We also host expert panels on immuno-oncology and quantitative TCR sequencing, demonstrating our commitment to scientific education and innovation. In 2023, we welcomed the Minister President of the Wallonia Region to our facilities, showcasing our role in advancing life sciences in Belgium[1].
Company roles mapping
This mapping combines roles declared by the company and roles identified by artificial intelligence from public data or past job offers. Some job titles are also standardised according to the European ESCO nomenclature (European Skills, Competences, Qualifications and Occupations) to ensure consistency with European skills frameworks. Learn more about AI transparency and ESCO →
No roles detected yet
The available public data does not yet allow us to identify the roles present with sufficient confidence. This mapping will automatically enrich itself as new information becomes available.
Employee distribution by work field
Estimate based on public data and company information. Learn more about AI transparency →






